CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 355 enrolled
Drug / intervention
EQUIPED-ADRD Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03723707
NCT03723707N/ACompleted

Enhanced Quality in Primary Care for Elders With Diabetes and Dementia

NYU Langone Health·interventional·Posted Oct 29, 2018·Updated Nov 9, 2023

In Brief

A clinical study evaluating EQUIPED-ADRD Intervention and Control (CON) for Diabetes and 2 related conditions. Completed, enrolled 355 participants across 1 site.

Detailed Summary

The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements supported by a panel manager(PM) for workflow support, electronic health record (EHR) decision support and feedback, and PCP collaborative learning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 29, 2018
Enrollment StartDec 3, 2018
Primary CompletionOct 20, 2022
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.7 years ago

Interventions

EQUIPED-ADRD Interventionbehavioral

(10 clinic sites and \~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)

Control (CON)behavioral

Will use current guidelines for primary care treatment with Diabetes and Dementia